Back to Search
Start Over
Isobutyryl-CoA dehydrogenase deficiency associated with autism in a girl without an alternative genetic diagnosis by trio whole exome sequencing
- Source :
- Molecular Genetics and Genomic Medicine, 9(2):e1595. John Wiley & Sons Inc., Molecular Genetics & Genomic Medicine, Molecular genetics & genomic medicine, 9(2):e1595. Wiley, Molecular Genetics & Genomic Medicine, Vol 9, Iss 2, Pp n/a-n/a (2021)
- Publication Year :
- 2021
-
Abstract
- Background Isobutyryl‐CoA dehydrogenase (IBD) is a mitochondrial enzyme catalysing the third step in the degradation of the essential branched‐chain amino acid valine and is encoded by ACAD8. ACAD8 mutations lead to isobutyryl‐CoA dehydrogenase deficiency (IBDD), which is identified by increased C4‐acylcarnitine levels. Affected individuals are either asymptomatic or display a variety of symptoms during infancy, including speech delay, cognitive impairment, failure to thrive, hypotonia, and emesis. Methods Here, we review all previously published IBDD patients and describe a girl diagnosed with IBDD who was presenting with autism as the main disease feature. Results To assess whether a phenotype‐genotype correlation exists that could explain the development or absence of clinical symptoms in IBDD, we compared CADD scores, in silico mutation predictions, LoF tolerance scores and C4‐acylcarnitine levels between symptomatic and asymptomatic individuals. Statistical analysis of these parameters did not establish significant differences amongst both groups. Conclusion As in our proband, trio whole exome sequencing did not establish an alternative secondary genetic diagnosis for autism, and reported long‐term follow‐up of IBDD patients is limited, it is possible that autism spectrum disorders could be one of the disease‐associated features. Further long‐term follow‐up is suggested in order to delineate the full clinical spectrum associated with IBDD.<br />Here, we review the clinical and molecular literature of Isobutyryl‐CoA dehydrogenase deficiency (IBDD) and present a novel case that was presenting with severe autism as the main disease feature. As extensive genetic analysis including trio whole exome sequencing did not establish a secondary cause for autism in this individual, and current reported follow‐up of IBDD individuals is limited, this case report might indicate that autism can be one of the IBDD manifestations.
- Subjects :
- 0301 basic medicine
Proband
INBORN-ERRORS
CHILDREN
QH426-470
030105 genetics & heredity
Bioinformatics
Acyl-CoA Dehydrogenase
whole exome sequencing
follow-up
Medicine
tandem mass-spectrometry
Child
genotype‐phenotype correlation
Genetics (clinical)
Exome sequencing
Clinical Report
ENCEPHALOPATHY
Hypotonia
Phenotype
Speech delay
Failure to thrive
Female
medicine.symptom
Oxidoreductases Acting on CH-CH Group Donors
DISORDERS
autism
genotype-phenotype correlation
ACAD8
Asymptomatic
Clinical Reports
03 medical and health sciences
Exome Sequencing
Genetics
Humans
Autistic Disorder
Amino Acid Metabolism, Inborn Errors
Molecular Biology
Isobutyryl-CoA Dehydrogenase Deficiency
IDENTIFICATION
business.industry
MUTATIONS
carnitine
isobutyryl-CoA dehydrogenase deficiency
medicine.disease
030104 developmental biology
Mutation
Autism
isobutyryl‐CoA dehydrogenase deficiency
business
Subjects
Details
- Language :
- English
- ISSN :
- 23249269
- Volume :
- 9
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Molecular Genetics and Genomic Medicine
- Accession number :
- edsair.doi.dedup.....c3db29dece762a6c6abac1191f040630
- Full Text :
- https://doi.org/10.1002/mgg3.1595